PLAU and prostate cancer: In the clinic, elevated uPA plasma level or uPA-uPA receptor densities are correlated with prostate cancer invasion, metastasis and poorer survival in prostate cancer [36,37] and its value as a prognostic marker has been well established in breast cancer [38,39].